L. Ozcan Et Al. , "Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation," International Urology and Nephrology , vol.47, no.2, pp.283-287, 2015
Ozcan, L. Et Al. 2015. Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation. International Urology and Nephrology , vol.47, no.2 , 283-287.
Ozcan, L., Polat, E. C., Otunctemur, A., & Ozbek, E., (2015). Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation. International Urology and Nephrology , vol.47, no.2, 283-287.
Ozcan, Levent Et Al. "Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation," International Urology and Nephrology , vol.47, no.2, 283-287, 2015
Ozcan, Levent Et Al. "Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation." International Urology and Nephrology , vol.47, no.2, pp.283-287, 2015
Ozcan, L. Et Al. (2015) . "Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation." International Urology and Nephrology , vol.47, no.2, pp.283-287.
@article{article, author={Levent Ozcan Et Al. }, title={Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation}, journal={International Urology and Nephrology}, year=2015, pages={283-287} }